L279-0150 Screening compound: 3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea

L279-0150 Screening compound: 3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea
L279-0150 Screening compound: 3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L279-0150
3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L279-0150

Molecular Formula

C24H29N5O2 (C24 H29 N5 O2)

Compound Name

3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-1,3-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea

IUPAC name

3-methyl-3-{[1-methyl-5-(pyrrolidine-1-carbonyl)-1H-13-benzodiazol-2-yl]methyl}-1-(2-phenylethyl)urea

SMILES

CN(Cc1nc(cc(cc2)C(N3CCCC3)=O)c2n1C)C(NCCc1ccccc1)=O

InChI

InChI=1S/C24H29N5O2/c1-27(24(31)25-13-12-18-8-4-3-5-9-18)17-22-26-20-16-19(10-11-21(20)28(22)2)23(30)29-14-6-7-15-29/h3-5,8-11,16H,6-7,12-15,17H2,1-2H3,(H,25,31)

InChI Key

VLMNKVUKFAFIMA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27239422

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.475

Distribution Coefficient, logD

2.474

Water Solubility, LogSw

-3.07

Polar Surface Area

55.374

Acid Dissociation Constant (pKa)

15.37

Base Dissociation Constant (pKb)

4.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

L279-0150 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Lipid Metabolism Library (9174 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L279-0150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L279-0150?
Check Price and Availability of L279-0150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L279-0150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L279-0150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L279-0150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L279-0150 available by request